Literature DB >> 81309

Rabbit antiserum against a non-T, non-B leukemia cell line that carries the Ph1 chromosome (NALM-1): antibody specific to a non-T, non-B acute lymphoblastic leukemia antigen.

H Koshiba, J Minowada, D Pressman.   

Abstract

Rabbit immune sera against human cells of a non-T, non-B leukemia cell line bearing the Ph1 chromosome (NALM-1) were characterized. After proper and exhaustive absorption, the sera were tested by indirect membrane immunofluorescence on a panel of 19 human hematopoietic cell lines with T-, B-, or non-T, non-B cell surface characteristics. The absorbed sera reacted specifically with NALM-1 cells but not with cells of another Ph1-positive cell line, K-562. Four of the 6 leukemia T-cell lines, 2 of the 4 leukemia-lymphoma B-cell lines, all of 4 acute lymphoblastic leukemia (ALL) lines with non-T, non-B cell characteristics, and uncultured cells of all patients with non-T, non-B cell ALL were reactive with the antisera. A cross-absorption study of the antisera suggested that a single antigenic complex is involved in this antigen specificity. The antigen involved appears to be a common non-T, non-B ALL one that has been described previously.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 81309

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  9 in total

1.  Autologous and allogeneic typing of human leukemia cells: definition of surface antigens restricted to lymphocytic leukemia cells.

Authors:  K Naito; H Yamaguchi; K Horibe; H Shiku; T Takahashi; S Suzuki; K Yamada
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

2.  Marker profiles of human leukemia and lymphoma cell lines.

Authors:  J Minowada; H Koshiba; K Sagawa; I Kubonishi; M S Lok; E Tatsumi; T Han; B I Srivastava; T Ohnuma
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

3.  New antigenic determinant common to human thymus leukaemia-associated antigens and common acute lymphoblastic leukaemia antigen.

Authors:  S Negoro; K Yoshizaki; E S Henderson; B K Seon
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

4.  Diagnostic specificity of the monoclonal anti-CALLA antibody VIL-A1 in leukemia and malignant lymphoma.

Authors:  W Knapp; D Lutz; P Bettelheim; T Radaszkiewicz; O Majdic; H Gadner
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

5.  Expression of a non-T, non-B ALL associated antigen on leukemic cells, lymphoblastoid cell lines and normal blood cells.

Authors:  H Winterleitner
Journal:  Blut       Date:  1980-05

6.  Phenotyping of malignant hematopoietic cells. Analysis of 1200 cases of leukemia-lymphoma.

Authors:  H G Drexler; M Menon; K Sagawa; E Tatsumi; H Koshiba; T Koishi; K Minato; T Sugimoto; M Saito; M Morita
Journal:  Blut       Date:  1986-02

7.  Detection of the common acute lymphoblastic leukemia antigen in the serum of leukemia patients.

Authors:  S Carrel; F Buchegger; D Heumann; C Girardet; C Barras; G Losa; J P Mach; V von Fliedner
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

8.  Immunochemical characterization of human TL-like (T48) and Ly 1-like (T72) glycoproteins using two-dimensional polyacrylamide gel electrophoresis.

Authors:  Y Ishii; J Fujimoto; S Kon; M Ogasawara; H Koshiba; A Matsuura; K Kikuchi
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

9.  Distribution of common acute lymphoblastic leukemia antigen in nonhematopoietic tissues.

Authors:  R S Metzgar; M J Borowitz; N H Jones; B L Dowell
Journal:  J Exp Med       Date:  1981-10-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.